{"id":5306,"date":"2023-09-13T13:47:22","date_gmt":"2023-09-13T17:47:22","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=5306"},"modified":"2026-04-13T14:37:09","modified_gmt":"2026-04-13T18:37:09","slug":"advancements-in-sensitivity-qpcrs-detection-of-proteins","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/fr\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/","title":{"rendered":"Advancements in Sensitivity: qPCR&#8217;s Detection of Proteins"},"content":{"rendered":"<p>L'un des aspects les plus remarquables de l'int\u00e9gration des aptam\u00e8res avec la qPCR pour la d\u00e9tection des prot\u00e9ines est la sensibilit\u00e9 sans pr\u00e9c\u00e9dent qu'elle apporte. Les m\u00e9thodes traditionnelles de d\u00e9tection des prot\u00e9ines, telles que l'ELISA et le Western blot, ont souvent du mal \u00e0 quantifier avec pr\u00e9cision les prot\u00e9ines pr\u00e9sentes \u00e0 tr\u00e8s faible concentration. Voici venir l'aptam\u00e8re-qPCR, une approche r\u00e9volutionnaire qui repousse les limites de la sensibilit\u00e9, permettant la d\u00e9tection sensible des prot\u00e9ines.<\/p>\n<p><strong>Franchir la barri\u00e8re de la sensibilit\u00e9<\/strong><\/p>\n<p>La sensibilit\u00e9 exquise de l'aptam\u00e8re-qPCR repose sur deux facteurs essentiels : la forte affinit\u00e9 de liaison des aptam\u00e8res et le pouvoir d'amplification exponentielle de la qPCR. Lorsqu'un aptam\u00e8re, soigneusement s\u00e9lectionn\u00e9 pour sa forte affinit\u00e9 envers une cible prot\u00e9ique, se lie \u00e0 la mol\u00e9cule cible, il forme un complexe stable. Ce complexe est ensuite captur\u00e9 et amplifi\u00e9 \u00e0 l'aide de la qPCR.<\/p>\n<p>La v\u00e9ritable magie op\u00e8re lors de l'\u00e9tape d'amplification de la qPCR. M\u00eame un seul complexe aptam\u00e8re-ADN prot\u00e9ique peut servir de mod\u00e8le pour l'amplification par qPCR, ce qui entra\u00eene une augmentation exponentielle du nombre de copies d'ADN. Ce processus d'amplification est semblable \u00e0 une loupe mol\u00e9culaire, permettant d'amplifier de mani\u00e8re significative et de quantifier m\u00eame de tr\u00e8s petites quantit\u00e9s de la prot\u00e9ine cible.<\/p>\n<p><strong>D\u00e9bloquer de nouvelles possibilit\u00e9s<\/strong><\/p>\n<p>Cette sensibilit\u00e9 accrue ouvre la porte \u00e0 de nombreuses possibilit\u00e9s passionnantes :<\/p>\n<ol>\n<li><strong>D\u00e9tection pr\u00e9coce des maladies :<\/strong> Dans les maladies o\u00f9 les biomarqueurs sont pr\u00e9sents en quantit\u00e9s minimes au stade pr\u00e9coce, l'aptamer-qPCR peut d\u00e9tecter ces prot\u00e9ines bien avant les m\u00e9thodes traditionnelles, permettant une intervention pr\u00e9coce et une am\u00e9lioration des r\u00e9sultats pour les patients. La plateforme Aptamarker de NeoVenture a d\u00e9montr\u00e9 une capacit\u00e9 remarquable \u00e0 identifier de mani\u00e8re agnostique les biomarqueurs cruciaux pour la d\u00e9tection pr\u00e9coce des maladies. Une r\u00e9cente validation lors d'une \u00e9tude pr\u00e9clinique en aveugle ax\u00e9e sur l'\u00e9valuation de la maladie d'Alzheimer \u00e0 travers les niveaux d'amylo\u00efde c\u00e9r\u00e9bral souligne le potentiel de la plateforme \u00e0 transformer le paysage du diagnostic m\u00e9dical. (Lien : https:\/\/neoaptamers.com\/successful-pre-clinical-trial-of-aptamer-based-blood-test-for-alzheimers-disease\/)<\/li>\n<li><strong>Des \u00e9chantillons de taille r\u00e9duite :<\/strong> La sensibilit\u00e9 de l'aptam\u00e8re-qPCR signifie que de plus petits volumes d'\u00e9chantillons sont suffisants pour quantifier pr\u00e9cis\u00e9ment les prot\u00e9ines, pr\u00e9servant ainsi les \u00e9chantillons pr\u00e9cieux, notamment dans des domaines tels que la recherche clinique o\u00f9 les \u00e9chantillons peuvent \u00eatre limit\u00e9s. Ces tests peuvent \u00eatre r\u00e9alis\u00e9s avec aussi peu que 10 \u00b5L d'\u00e9chantillon.<\/li>\n<li><strong>De nouvelles informations sur les processus biologiques :<\/strong> Les prot\u00e9ines pr\u00e9c\u00e9demment ind\u00e9tectables \u00e0 des concentrations ultra-faibles peuvent maintenant \u00eatre quantifi\u00e9es, \u00e9clairant les processus cellulaires complexes et les interactions mol\u00e9culaires. La plateforme Aptamarker de NeoVenture peut \u00eatre con\u00e7ue pour fonctionner de mani\u00e8re similaire \u00e0 la prot\u00e9omique, permettant le suivi m\u00e9ticuleux et l'identification des changements de prot\u00e9ines entre les \u00e9chantillons, m\u00eame dans les cas de faibles concentrations.<\/li>\n<li><strong>La surveillance des changements dynamiques :<\/strong> L'aptam\u00e8re-qPCR est capable de surveiller les changements rapides dans les concentrations de prot\u00e9ines, offrant ainsi une vue dynamique des r\u00e9ponses cellulaires et des \u00e9v\u00e9nements de signalisation.<\/li>\n<\/ol>\n<p><strong>D\u00e9fis et consid\u00e9rations<\/strong><\/p>\n<p>Bien que la capacit\u00e9 \u00e0 d\u00e9tecter des concentrations tr\u00e8s faibles de prot\u00e9ines soit une r\u00e9alisation monumentale, il est important de noter que pour atteindre ce niveau de sensibilit\u00e9, une optimisation minutieuse de diverses \u00e9tapes de l'analyse est n\u00e9cessaire. Ces \u00e9tapes comprennent la s\u00e9lection des aptam\u00e8res, la conception des sondes et les conditions de qPCR. De plus, des mesures doivent \u00eatre prises pour minimiser les signaux de fond et la liaison non sp\u00e9cifique, qui peuvent devenir plus prononc\u00e9s \u00e0 de telles concentrations cibles faibles.<\/p>\n<p>Chez NeoVentures, notre vaste exp\u00e9rience nous positionne en tant qu'experts dans l'optimisation et la sensibilit\u00e9 maximale des exp\u00e9riences de qPCR. Notre \u00e9quipe est d\u00e9di\u00e9e \u00e0 l'affinage et \u00e0 la maximisation du potentiel des analyses qPCR, garantissant ainsi que les chercheurs peuvent exploiter pleinement cette technique puissante. Nous comprenons les subtilit\u00e9s et les complexit\u00e9s du flux de travail de qPCR, ce qui nous permet de fournir des r\u00e9sultats pr\u00e9cis, fiables et reproductibles pour un large \u00e9ventail de travaux scientifiques. Que ce soit pour repousser les limites des limites de d\u00e9tection ou pour optimiser les param\u00e8tres exp\u00e9rimentaux, NeoVentures travaillera avec vous pour faire progresser votre technologie de qPCR dans le cadre de recherches r\u00e9volutionnaires.<\/p>\n<p>L'association des aptam\u00e8res et de la qPCR a non seulement combl\u00e9 le foss\u00e9 entre l'analyse des acides nucl\u00e9iques et des prot\u00e9ines, mais a \u00e9galement bris\u00e9 les limites de la sensibilit\u00e9 de d\u00e9tection des prot\u00e9ines. La synergie entre la haute sp\u00e9cificit\u00e9 et l'affinit\u00e9 des aptam\u00e8res et la capacit\u00e9 d'amplification exponentielle de la qPCR a ouvert un nouveau domaine d'analyse des prot\u00e9ines, permettant la d\u00e9tection et la quantification des prot\u00e9ines \u00e0 de faibles concentrations. \u00c0 mesure que cette technologie continue d'\u00e9voluer et de s'int\u00e9grer dans divers domaines, elle a le potentiel de remodeler notre compr\u00e9hension des maladies, de la biologie et au-del\u00e0.<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>One of the most remarkable aspects of the integration of aptamers with qPCR for protein detection is the unprecedented sensitivity it brings to the table. Traditional protein detection methods, such as ELISA and Western blotting, often struggle to accurately quantify proteins present in very low concentrations. Enter aptamer-qPCR, a game-changing approach that pushes the boundaries&hellip;&nbsp;<a href=\"https:\/\/neoaptamers.com\/fr\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/\" rel=\"bookmark\">Lire la suite &raquo;<span class=\"screen-reader-text\">Advancements in Sensitivity: qPCR&#8217;s Detection of Proteins<\/span><\/a><\/p>","protected":false},"author":2,"featured_media":5308,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[8],"tags":[],"class_list":["post-5306","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aptamers"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Advancements in Sensitivity: qPCR&#039;s Detection of Proteins<\/title>\n<meta name=\"description\" content=\"Advancements in sensitivity with qPCR allows for ultra-sensitive protein quantification, early disease detection, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/fr\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Advancements in Sensitivity: qPCR&#039;s Detection of Proteins\" \/>\n<meta property=\"og:description\" content=\"Advancements in sensitivity with qPCR allows for ultra-sensitive protein quantification, early disease detection, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/fr\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-13T17:47:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T18:37:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/09\/Blog-images2-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gregory Penner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gregory Penner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/advancements-in-sensitivity-qpcrs-detection-of-proteins\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/advancements-in-sensitivity-qpcrs-detection-of-proteins\\\/\"},\"author\":{\"name\":\"Gregory Penner\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\"},\"headline\":\"Advancements in Sensitivity: qPCR&#8217;s Detection of Proteins\",\"datePublished\":\"2023-09-13T17:47:22+00:00\",\"dateModified\":\"2026-04-13T18:37:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/advancements-in-sensitivity-qpcrs-detection-of-proteins\\\/\"},\"wordCount\":661,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/advancements-in-sensitivity-qpcrs-detection-of-proteins\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Blog-images2-1.png\",\"articleSection\":[\"Aptamers\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/advancements-in-sensitivity-qpcrs-detection-of-proteins\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/advancements-in-sensitivity-qpcrs-detection-of-proteins\\\/\",\"name\":\"Advancements in Sensitivity: qPCR's Detection of Proteins\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/advancements-in-sensitivity-qpcrs-detection-of-proteins\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/advancements-in-sensitivity-qpcrs-detection-of-proteins\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Blog-images2-1.png\",\"datePublished\":\"2023-09-13T17:47:22+00:00\",\"dateModified\":\"2026-04-13T18:37:09+00:00\",\"description\":\"Advancements in sensitivity with qPCR allows for ultra-sensitive protein quantification, early disease detection, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/advancements-in-sensitivity-qpcrs-detection-of-proteins\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/advancements-in-sensitivity-qpcrs-detection-of-proteins\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/advancements-in-sensitivity-qpcrs-detection-of-proteins\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Blog-images2-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Blog-images2-1.png\",\"width\":1000,\"height\":800,\"caption\":\"Microscope\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/advancements-in-sensitivity-qpcrs-detection-of-proteins\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Advancements in Sensitivity: qPCR&#8217;s Detection of Proteins\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\",\"name\":\"Gregory Penner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"caption\":\"Gregory Penner\"},\"description\":\"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Advancements in Sensitivity: qPCR's Detection of Proteins","description":"Advancements in sensitivity with qPCR allows for ultra-sensitive protein quantification, early disease detection, and more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/fr\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/","og_locale":"fr_FR","og_type":"article","og_title":"Advancements in Sensitivity: qPCR's Detection of Proteins","og_description":"Advancements in sensitivity with qPCR allows for ultra-sensitive protein quantification, early disease detection, and more.","og_url":"https:\/\/neoaptamers.com\/fr\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/","og_site_name":"neoaptamers","article_published_time":"2023-09-13T17:47:22+00:00","article_modified_time":"2026-04-13T18:37:09+00:00","og_image":[{"width":1000,"height":800,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/09\/Blog-images2-1.png","type":"image\/png"}],"author":"Gregory Penner","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Gregory Penner","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/"},"author":{"name":"Gregory Penner","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad"},"headline":"Advancements in Sensitivity: qPCR&#8217;s Detection of Proteins","datePublished":"2023-09-13T17:47:22+00:00","dateModified":"2026-04-13T18:37:09+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/"},"wordCount":661,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/09\/Blog-images2-1.png","articleSection":["Aptamers"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/","url":"https:\/\/neoaptamers.com\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/","name":"Advancements in Sensitivity: qPCR's Detection of Proteins","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/09\/Blog-images2-1.png","datePublished":"2023-09-13T17:47:22+00:00","dateModified":"2026-04-13T18:37:09+00:00","description":"Advancements in sensitivity with qPCR allows for ultra-sensitive protein quantification, early disease detection, and more.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/09\/Blog-images2-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/09\/Blog-images2-1.png","width":1000,"height":800,"caption":"Microscope"},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/advancements-in-sensitivity-qpcrs-detection-of-proteins\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"Advancements in Sensitivity: qPCR&#8217;s Detection of Proteins"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad","name":"Gregory Penner","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","caption":"Gregory Penner"},"description":"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team."}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5306","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/comments?post=5306"}],"version-history":[{"count":4,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5306\/revisions"}],"predecessor-version":[{"id":6503,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5306\/revisions\/6503"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media\/5308"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media?parent=5306"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/categories?post=5306"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/tags?post=5306"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}